ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

Abroad (travel likely)Recruiting

Conditions

Cardiotoxicity · Heart Failure · Neoplasms · Breast Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU de Caen, Caen, France
Contact: Study coordinator (Damien Legallois, MD) · +33231065118

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Ventricular Ejection Fraction · LVF · LV Dysfunction

Abroad (travel likely)Recruiting

Orange, United States · Pasadena, United States

Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-B

Breast Neoplasms

Abroad (travel likely)Recruiting

Strasbourg, France

Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study

Breast Cancer · Disability Physical · Heart Failure

Abroad (travel likely)Recruiting

Edmonton, Canada

The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial

Heart Failure · Cardiotoxicity · Cancer

Abroad (travel likely)Recruiting

Toronto, Canada